Milestone Scientific to Participate in the 146th Chicago Dental Society Midwinter Meeting on February 24-26, 2011

-- Will Demonstrate Its Single Tooth Anesthesia System --

LIVINGSTON, N.J.--(BUSINESS WIRE)-- Milestone Scientific Inc. (OTC BB: MLSS), the recognized leader in advanced, computer-controlled drug delivery technologies, will participate in the 146th Chicago Dental Society Midwinter Meeting in Chicago at the McCormick Place West Building, at Booth # 1513.

Joseph D'Agostino, Chief Financial Officer said, "We are looking forward to participating in this conference, one of the top three dental conferences in the U.S. Based upon the great response we had at the recent AAGDP meeting in Orlando, we expect to meet with potential new customers and demonstrate how Milestone's Single Tooth Anesthesia System(R) ("STA") can help dental practices differentiate themselves in the marketplace, and how we are leading the way towards painless, safe, fast and scientifically advanced dentistry."

"Key members of our management team as well as our dental hygienists will be at the conference. They will demonstrate how the STA instrument has revolutionized dentistry, and how it can help increase their efficiency and positively impact their growth," he concluded.

About Milestone Scientific Inc.

Milestone Scientific is engaged in pioneering advanced computer-controlled drug delivery technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North America, Central and South America, Asia, Africa and Europe. For more information on the STA Single Tooth Anesthesia System(R) and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com or follow the Company on Twitter @painlessdental or become a fan on Facebook at Painless Dentistry.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2009. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.


    Source: Milestone Scientific Inc.